APPLICATION OF PCSK9 INHIBITOR FOR THE TREATMENT OF HYPERLIPIDEMIA

摘要

The present invention relates to methods for treating hyperlipidemia in patients who do not receive statin therapy. The methods of the present invention comprise administering to a patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody, such as an illustrative antibody, referred to herein as mAb316P.